Cargando…
Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors
The Wnt-pathway has a critical role in development and tissue homeostasis and has attracted increased attention to develop anticancer drugs due to its aberrant activation in many cancers. In this study, we identified a novel small molecule series with a thienopyrimidine scaffold acting as a downstre...
Autores principales: | Boudou, Cédric, Mattio, Luce, Koval, Alexey, Soulard, Valentin, Katanaev, Vladimir L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649909/ https://www.ncbi.nlm.nih.gov/pubmed/36386148 http://dx.doi.org/10.3389/fphar.2022.1045102 |
Ejemplares similares
-
Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors
por: Frontiers Production Office,
Publicado: (2023) -
High-throughput targeted screening in triple-negative breast cancer cells identifies Wnt-inhibiting activities in Pacific brittle stars
por: Blagodatski, Artem, et al.
Publicado: (2017) -
Dramatic dysbalancing of the Wnt pathway in breast cancers
por: Koval, Alexey, et al.
Publicado: (2018) -
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers
por: Ahmed, Kamal, et al.
Publicado: (2016) -
Beyond TNBC: Repositioning of Clofazimine Against a Broad Range of Wnt-Dependent Cancers
por: Xu, Jiabin, et al.
Publicado: (2020)